Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) FCF Margin (2017 - 2025)

Historic FCF Margin for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to 0.56%.

  • Organogenesis Holdings' FCF Margin fell 47600.0% to 0.56% in Q3 2025 from the same period last year, while for Sep 2025 it was 11.1%, marking a year-over-year decrease of 119600.0%. This contributed to the annual value of 0.87% for FY2024, which is 6500.0% down from last year.
  • Per Organogenesis Holdings' latest filing, its FCF Margin stood at 0.56% for Q3 2025, which was down 47600.0% from 36.15% recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' FCF Margin registered a high of 10.67% during Q2 2021, and its lowest value of 36.15% during Q2 2025.
  • For the 5-year period, Organogenesis Holdings' FCF Margin averaged around 2.03%, with its median value being 0.98% (2023).
  • Per our database at Business Quant, Organogenesis Holdings' FCF Margin soared by 287700bps in 2021 and then tumbled by -383400bps in 2025.
  • Over the past 5 years, Organogenesis Holdings' FCF Margin (Quarter) stood at 9.95% in 2021, then crashed by -125bps to 2.47% in 2022, then surged by 396bps to 7.32% in 2023, then dropped by -18bps to 5.98% in 2024, then plummeted by -91bps to 0.56% in 2025.
  • Its FCF Margin was 0.56% in Q3 2025, compared to 36.15% in Q2 2025 and 27.18% in Q1 2025.